Development of In Vitro Susceptibility Testing Criteria and Quality Control Parameters for Veterinary Antimicrobial Agents; Approved Guideline\u2014Second Edition<\/p>\n","protected":false},"excerpt":{"rendered":"
NCCLS document M37-A2\u2014Development of In Vitro Susceptibility Testing Criteria and Quality Control Parameters for Veterinary Antimicrobial Agents; Approved Guideline \u2014Second Edition offers guidance for developing agar disk diffusion zones of inhibition, dilution MIC breakpoints, and quality control limits for antimicrobial susceptibility testing of aerobic and anaerobic bacteria isolated from animals. It is intended to be used in establishing interpretive and quality control criteria for NCCLS antimicrobial susceptibility testing standards for antimicrobial agents intended for veterinary use. Host-specific pharmacokinetics, in vitro drug characteristics, distributions of microorganisms, and correlation of test results with outcome statistics are addressed from the perspective of interpretation of test results. In addition, this document addresses clinical confirmation of interpretive criteria and quality control limits. For clinical confirmation, the \u201cideal\u201d data set may not be obtained during development of a new drug. Users of this guideline should understand the limitations and work toward the best-educated conclusions. NCCLS. Development of In Vitro Susceptibility Testing Criteria and Quality Control Parameters for Veterinary Antimicrobial Agents; Approved Guideline \u2014Second Edition. NCCLS document M37-A2 (ISBN 1-56238-462-7). NCCLS, 940 West Valley Road, Suite 1400, Wayne, Pennsylvania 19087-1898, USA 2002.<\/p>\n","protected":false},"featured_media":1805,"comment_status":"open","ping_status":"closed","template":"","meta":[],"product_cat":[26],"product_tag":[],"yoast_head":"\n